Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-14
1999-09-07
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 514415, 514417, 514432, 514441, A61K 3147, A61K 31405, A61K 3140, A61K 3138
Patent
active
059488131
ABSTRACT:
A method for suppressing the rejection of allogeneic transplants in a mammal, including a human, comprising administering to said mammal an effective amount of the compound of the formula ##STR1## wherein n, A, B, R.sup.1 and R.sup.2 are as defined above, or the pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 5550152 (1996-08-01), Koch et al.
patent: 5552435 (1996-09-01), Koch
Nilsson et al. European Surgical Research, 17(3) 173-8 (Abstract), 1988.
Showell Henry J.
Weringer Elora J.
Appleman Jolene W.
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
Travers Russell
LandOfFree
Method of preventing allograft rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preventing allograft rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing allograft rejection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804931